PMID: 11899794Mar 20, 2002Paper

Efficiency treatment of new cases of destructive pulmonary tuberculosis in the presence of concurrent iron deficiency anemia

Problemy tuberkuleza
V V Voloshina, N I Fomicheva

Abstract

A hundred and twenty nine new cases of destructive pulmonary tuberculosis were examined. Of them, 95 patients were diagnosed as having first-degree iron deficiency anemia. Anemia was found to have a negative impact on the clinical efficiency of therapeutical measures. For correction of anemia, the use of antioxidants (tocopherol acetate, ascorbic acid) and an antihypoxant (riboxine) yielded better clinical results than did an iron-containing agent (ferroplex). These results were mostly close to those obtained in a group of patients without anemia.

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.